KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Moderna (MRNA) Shares Outstanding: 2016-2022

Historic Shares Outstanding for Moderna (MRNA) over the last 5 years, with Dec 2022 value amounting to $385.0 million.

  • Moderna's Shares Outstanding fell 4.47% to $385.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $385.0 million, marking a year-over-year decrease of 4.47%. This contributed to the annual value of $385.0 million for FY2022, which is 4.47% down from last year.
  • As of Q4 2022, Moderna's Shares Outstanding stood at $385.0 million, which was down 1.79% from $392.0 million recorded in Q2 2022.
  • In the past 5 years, Moderna's Shares Outstanding ranged from a high of $509.4 million in Q2 2018 and a low of $328.9 million during Q1 2019.
  • Its 3-year average for Shares Outstanding is $395.1 million, with a median of $399.0 million in 2020.
  • In the last 5 years, Moderna's Shares Outstanding skyrocketed by 404.55% in 2018 and then crashed by 35.22% in 2019.
  • Quarterly analysis of 5 years shows Moderna's Shares Outstanding stood at $329.0 million in 2018, then climbed by 2.43% to $337.0 million in 2019, then grew by 18.40% to $399.0 million in 2020, then climbed by 1.00% to $403.0 million in 2021, then fell by 4.47% to $385.0 million in 2022.
  • Its Shares Outstanding stands at $385.0 million for Q4 2022, versus $392.0 million for Q2 2022 and $400.0 million for Q1 2022.